Lancer Orthodontics ROE 1971-1970 | LANZ

Current and historical return on equity (ROE) values for Lancer Orthodontics (LANZ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Lancer Orthodontics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Lancer Orthodontics develops, manufactures and markets state-of-the-art orthodontic products such as bands, brackets and buccal tubes worldwide. It is the only freestanding public company in the field of orthodontic manufacturing.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.591B 21.63
Becton Dickinson (BDX) United States $49.119B 12.16
Cardinal Health (CAH) United States $36.458B 19.09
Straumann Holding AG (SAUHY) Switzerland $20.442B 0.00
Labcorp (LH) United States $20.300B 16.47
Cooper (COO) United States $15.765B 20.91
West Pharmaceutical Services (WST) United States $14.771B 30.96
Align Technology (ALGN) United States $12.380B 24.58
Henry Schein (HSIC) United States $8.721B 14.96
Merit Medical Systems (MMSI) United States $5.637B 27.25
DENTSPLY SIRONA (XRAY) United States $3.083B 9.21
CONMED (CNMD) United States $1.714B 12.82
STAAR Surgical (STAA) United States $0.925B 0.00
Lifevantage (LFVN) United States $0.159B 16.44
Pro-Dex (PDEX) United States $0.151B 16.51